In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Encore closes Compex acquisition:

This article was originally published in Clinica

Executive Summary

Austin, Texas-based orthopaedic firm Encore Medical has completed its acquisition of Compex Technologies, an electrical stimulation products manufacturer. Encore exchanged around 18 million shares of its common stock for the New Brighton, Minnesota company and has incurred a debt of $17m to pay off Compex' existing debt. Compex' president and CEO, and its president of worldwide consumer products, Marshall Masko, have both resigned from their positions. Kenneth Davidson, Encore's chairman and CEO, will head its new Compex subsidiary.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts